TNBC Foundation Supports Research
The Triple Negative Breast Cancer Foundation is committed to funding breakthrough research to support the discovery of promising new treatments for TNBC patients. Since our inception in 2006, we have awarded over three million dollars to major research institutions working toward a targeted therapy for triple negative breast cancer.
A clinical trial is a research study that investigates new or emerging treatments for a disease. TNBC Foundation offers two clinical trial matching services to help connect patients with trials that match their exact diagnosis, stage and treatment history.
Updates from Medical Conferences
On behalf of our TNBC community, we attend and report on major medical conferences including the San Antonio Breast Cancer Symposium, American Association for Cancer Research and the American Society of Clinical Oncology.